1N
1N9.F NeutriSci International Inc
- Market cap
- EUR 600K
- P/E
- -
- P/B
- 15.21x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 1N9.F undervalued?
Graham numberThe Graham number of NeutriSci International Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NeutriSci International Inc fundamental analysis
No fundamental analysis for NeutriSci International Inc yet.
NeutriSci International Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NeutriSci International Inc
NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Full company profileNeutriSci International Inc financial statements
NeutriSci International Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 125K | 151K | 82.7K | 96.5K | 74.6K | 80.9K | 458K | 60.0K |
| Gross Profit | 25.4K | -10.7K | 3.91K | 2.94K | -5.87K | -20.5K | -43.4K | -26.3K |
| Operating Income | -2.59M | -2.09M | -2.28M | -1.65M | -1.94M | -1.39M | -690K | -505K |
| EBITDA | - | -2.08M | -2.36M | -1.61M | -1.92M | -1.53M | -733K | - |
| Net Income | -2.56M | -2.12M | -2.38M | -1.61M | -1.95M | -1.57M | -771K | -552K |
| EPS | - | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | 0.00 | - |
| Balance Sheet | ||||||||
| Total Assets | 1.14M | 601K | 554K | 505K | 528K | 820K | 331K | - |
| Total Liabilities | 476K | 470K | 278K | 661K | 619K | 867K | 948K | - |
| Shareholders' Equity | 664K | 131K | 276K | -156K | -90.2K | -47.6K | -617K | - |
| Cash & Short-term Investments | 806K | 356K | 275K | 100.00 | 7.37K | 30.7K | 175K | - |
| Cash Flow | ||||||||
| Operating Cash Flow | -2.26M | -1.51M | -2.05M | -1.24M | -1.52M | -166K | -166K | -265K |
| Capital Expenditure | 1.71K | 28.2K | 28.2K | 110K | 110K | 4.76K | 4.76K | 0.00 |
| Free Cash Flow | - | -1.51M | -2.07M | -1.24M | -1.63M | -1.15M | -171K | -265K |
| Ratios | ||||||||
| ROE | -386.1% | -1,615.3% | -864.0% | - | - | - | - | - |
| ROA | -225.0% | -353.1% | -430.5% | -319.5% | -369.6% | -191.8% | -232.5% | - |
| Net Profit Margin | -2,046.1% | -1,404.8% | -2,882.7% | -1,670.7% | -2,618.3% | -1,943.5% | -168.4% | -921.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
NeutriSci International Inc dividends
NeutriSci International Inc has not paid dividends in the last 8 fiscal years.
Who owns NeutriSci International Inc
- Insiders 1.03%
- Institutions 0.00%
- Public & others 98.97%
- Shares outstanding 178M
- Free float 176M
NeutriSci International Inc company profile
- Company name
- NeutriSci International Inc
- Ticker
- 1N9.F
- ISIN
- CA64129Y1079
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- 1600 ? 609 Granville Street, Vancouver, BC, Canada, V7Y 1C3
- Phone
- 403 264 6320
- Website
- neutrisci.com
About NeutriSci International Inc
NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
NeutriSci International Inc management
4- Mr. Glen RehmanCEO, President & Director
- Mr. John Robert ChisholmChief Financial Officer · born 1962
- Ms. Jaycee WatersOperations & Logistics Manager
- Mr. Thierry SorhaitzVice President of Sales & Marketing